Target Price | $34.33 |
Price | $19.10 |
Potential |
79.76%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target Syndax Pharmaceuticals Inc 2025 .
The average Syndax Pharmaceuticals Inc target price is $34.33.
This is
79.76%
register free of charge
$45.00
135.60%
register free of charge
$23.00
20.42%
register free of charge
|
|
A rating was issued by 13 analysts: 12 Analysts recommend Syndax Pharmaceuticals Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Syndax Pharmaceuticals Inc stock has an average upside potential 2025 of
79.76%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.00 | 31.53 |
12 Analysts have issued a sales forecast Syndax Pharmaceuticals Inc 2024 . The average Syndax Pharmaceuticals Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Syndax Pharmaceuticals Inc EBITDA forecast 2024. The average Syndax Pharmaceuticals Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Syndax Pharmaceuticals Inc Analysts have issued a net profit forecast 2024. The average Syndax Pharmaceuticals Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.98 | -3.75 |
21.14% | 25.84% | |
P/E | negative | |
EV/Sales | 38.10 |
13 Analysts have issued a Syndax Pharmaceuticals Inc forecast for earnings per share. The average Syndax Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Syndax Pharmaceuticals Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Syndax Pharmaceuticals Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.